((自动化翻译由路透提供，请见免责声明 ))
10月4日 - ** 合约药品生产商赛默飞世尔 股价盘前下跌1.6%，报591.31美元
** 路透援引美国食品和药物管理局（FDA）的文件报导，TMO的一家生产厂在过去十年中多次违反旨在确保药品不受污染的规定， (link)。
** 该厂位于北卡罗来纳州格林维尔，是美国最大的合同药品生产厂之一。
** 该厂生产约 40 种不同的药品，其中包括诺和诺德 的流行减肥药 Wegovy。
** 截至上次收盘，TMO 的涨幅约为 13%，而标准普尔 500 指数 的涨幅为 19.5
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.